# Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)

> **NCT02340819** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 11 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** Teduglutide

## Key facts

- **NCT ID:** NCT02340819
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-18
- **Primary completion:** 2018-11-05
- **Final completion:** 2018-11-05
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02340819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02340819, "Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02340819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*